Volv Global

Machine Learning Maps and Discovers Clinical Endpoints in Pompe Disease Using Real-World Data

In the largest machine learning study of Pompe disease to date, Volv Global demonstrates that clinician-defined endpoints can be tracked and novel disease features discovered in US claims data across 3,549 patients In brief: Real-world claims data can serve as a reliable evidence foundation for Pompe disease, with literature-based symptoms confirmed as both identifiable and...
Rte de la Corniche 3, 1066 Epalinges, Switzerland